Post by Coriolis Pharma

Nucleic acid therapeutics (NATs) are revolutionizing medicine but the road from mRNA, siRNA, or ASO sequence to a market-ready drug is notoriously steep. 🧬 Inherent molecular instability, complex LNP delivery systems, and expensive cold-chain logistics present massive formulation and manufacturing hurdles. Failing to address these early can completely halt a promising program. In our latest article, "De-Risk Nucleic Acid Therapeutic Development With Strategic Outsourcing And Specialized Expertise," we break down how to navigate these early-phase pitfalls. 👉 Read the full article for actionable de-risking strategies: https://lnkd.in/eb4PKKny #Pharma #NucleicAcidTherapeutics #Biotech #mRNA #DrugDevelopment #CoriolisPharma